PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1968 August; 47(8): 1858–1864.
PMCID: PMC297346

Studies of red cell stromal proteins in Tay-Sachs disease

Abstract

Hemoglobin-free red blood cell ghosts of nine patients with Tay-Sachs disease and 14 normal control subjects have been analyzed for content of total protein, hexosamines, individual amino acids, and sialic acid. Red cell ghosts from Tay-Sachs' children have been shown to contain significantly increased amounts of protein, hexosamine, threonine, and serine, and probably sialic acid, each of which was increased by approximately 25% over control values. These observations suggest that the red cell membrane in patients with Tay-Sachs disease contains a significant excess of a glycoprotein or proteins, as compared with normal, and that the metabolic defect in this disease, therefore, affects glycoproteins as well as complex lipids.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (980K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BALINT JA, SPITZER HL, KYRIAKIDES EC. STUDIES OF RED-CELL STROMAL LIPIDS IN TAY-SACHS DISEASE AND OTHER LIPIDOSES. J Clin Invest. 1963 Nov;42:1661–1668. [PMC free article] [PubMed]
  • DODGE JT, MITCHELL C, HANAHAN DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 1963 Jan;100:119–130. [PubMed]
  • CROSBY WH, FURTH FW. A modification of the benzidine method for measurement of hemoglobin in plasma and urine. Blood. 1956 Apr;11(4):380–383. [PubMed]
  • BOAS NF. Method for the determination of hexosamines in tissues. J Biol Chem. 1953 Oct;204(2):553–563. [PubMed]
  • Simó-Camps E, Anguers A, Ma Vich J, Vidal-Ribas A, Sala F, Sarrias R, Gumma J, Gri E, Ma Puigdollers J. Immunologic impairment in patients with non-lymphoid cancer: correlation with the tumoral stage, response to treatment and survival. Cancer. 1976 Feb;37(2):724–728. [PubMed]
  • WARREN L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959 Aug;234(8):1971–1975. [PubMed]
  • SVENNERHOLM L. THE DISTRIBUTION OF LIPIDS IN THE HUMAN NERVOUS SYSTEM. I. ANALYTICAL PROCEDURE. LIPIDS OF FOETAL AND NEWBORN BRAIN. J Neurochem. 1964 Dec;11:839–853. [PubMed]
  • Morgan TE, Hanahan DJ. Solubilization and characterization of a lipoprotein from erythrocyte stroma. Biochemistry. 1966 Mar;5(3):1050–1059. [PubMed]
  • Bakerman S, Wasemiller G. Studies on structural units of human erythrocyte membrane. I. Separation, isolation, and partial characterization. Biochemistry. 1967 Apr;6(4):1100–1113. [PubMed]
  • Hooghwinkel GJ, Borri PF, Bruyn GW. Biochemical studies in Huntington's chorea. II. Composition of blood lipids. Acta Neurol Scand. 1966;42(2):213–220. [PubMed]
  • EYLAR EH, MADOFF MA, BRODY OV, ONCLEY JL. The contribution of sialic acid to the surface charge of the erythrocyte. J Biol Chem. 1962 Jun;237:1992–2000. [PubMed]
  • MAKELA O, MIETTINEN T, PESOLA R. Release of sialic acid and carbohydrates from human red cells by trypsin treatment. Vox Sang. 1960 Sep;5:492–496. [PubMed]
  • KATHAN RH, WINZLER RJ. Structure studies on the myxovirus hemagglutination inhibitor of human erythrocytes. J Biol Chem. 1963 Jan;238:21–25. [PubMed]
  • Winzler RJ, Harris ED, Pekas DJ, Johnson CA, Weber P. Studies on glycopeptides released by trypsin from intact human erythrocytes. Biochemistry. 1967 Jul;6(7):2195–2202. [PubMed]
  • HASHIMOTO Y, TSUIKI S, NISIZAWA K, PIGMAN W. Action of proteolytic enzymes on purified bovine submaxillary mucin. Ann N Y Acad Sci. 1963 Mar 30;106:233–246. [PubMed]
  • Bhargava AS, Gottschalk A. Studies on glycoproteins. XVI. Serine and threonine residues., the only identifiable sugar acceptors in ovine submaxillary gland glycoprotein. Biochim Biophys Acta. 1967 Oct 9;148(1):132–136. [PubMed]
  • Eeg-Olofsson L, Kristensson K, Sourander P, Svennerholm L. Tay-Sachs disease. A generalized metabolic disorder. Acta Paediatr Scand. 1966 Nov;55(6):546–562. [PubMed]
  • Brady RO. The sphingolipidoses. N Engl J Med. 1966 Aug 11;275(6):312–318. [PubMed]
  • Basu S, Kaufman B, Roseman S. Conversion of Tay-Sachs ganglioside to monosialoganglioside by brain uridine diphosphate D-galactose: glycolipid galactosyltransferase. J Biol Chem. 1965 Oct;240(10):4115–4117. [PubMed]
  • GATT S, BERMAN ER. Studies on brain lipids in Tay-Sachs' disease. III. Incorporation of tritiated water into brain lipids. J Neurochem. 1963 Feb;10:73–77. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation